Inflammatory subphenotypes in patients at risk of ARDS: evidence from the LIPS-A trial.
Redaelli S, von Wedel D, Fosset M, Suleiman A, Chen G, Alingrin J, Gong MN, Gajic O, Goodspeed V, Talmor D, Schaefer MS, Jung B.
Redaelli S, et al. Among authors: von wedel d.
Intensive Care Med. 2023 Dec;49(12):1499-1507. doi: 10.1007/s00134-023-07244-z. Epub 2023 Oct 31.
Intensive Care Med. 2023.
PMID: 37906258
Clinical Trial.